(Q38099240)

28 August 2017

Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system (English)

1 reference

Chronic prostatitis/chronic pelvic pain syndrome

28 August 2017

0 references

1 reference

Daniel A Shoskes

1

1 reference

28 August 2017

J Curtis Nickel

series ordinal

2

1 reference

28 August 2017

language of work or name

1 reference

16 April 2013

1 reference

28 August 2017

World Journal of Urology

1 reference

28 August 2017

31

1 reference

28 August 2017

755-760

1 reference

28 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s00345-013-1075-6

28 August 2017

0 references

cites work

Clinical significance of IL-2, IL-10, and TNF-alpha in prostatic secretion of patients with chronic prostatitis

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Chronic prostatitis/chronic pelvic pain syndrome and pelvic floor spasm: can we diagnose and treat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Treatment of category III A prostatitis with zafirlukast: a randomized controlled feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Effects of pollen extract preparation Prostat/Poltit on lower urinary tract symptoms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

6-day intensive treatment protocol for refractory chronic prostatitis/chronic pelvic pain syndrome using myofascial release and paradoxical relaxation training

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Clustering of UPOINT domains and subdomains in men with chronic prostatitis/chronic pelvic pain syndrome and contribution to symptom severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Evaluation of a modification of the UPOINT clinical phenotype system for the chronic pelvic pain syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Is a sexual dysfunction domain important for quality of life in men with urological chronic pelvic pain syndrome? Signs "UPOINT" to yes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Inclusion of erectile domain to UPOINT phenotype does not improve correlation with symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-013-1075-6

Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretion

21 January 2018

1 reference

12 December 2020

A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study

1 reference

12 December 2020

Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study

1 reference

12 December 2020

Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes

1 reference

12 December 2020

A case-control study of risk factors in men with chronic pelvic pain syndrome

1 reference

12 December 2020

Use of antibiotics in chronic prostatitis syndromes.

1 reference

12 December 2020

Silodosin for men with chronic prostatitis/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study

1 reference

12 December 2020

10.1007/S00345-013-1075-6

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference